Seelos Therapeutics, Inc.

WELLS FARGO & COMPANY/MN

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

30,929

Value ($000)

6

Weight

0.0%

2019 Q4 - 2023 Q3 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	6	0.0%	30,929	9/30/2023
2023 Q2	8/15/2023	37	0.0%	30,877	6/30/2023
2023 Q1	5/12/2023	21	0.0%	30,741	3/31/2023
2022 Q4	2/13/2023	21	0.0%	30,730	12/31/2022
2022 Q3	11/14/2022	40	0.0%	38,708	9/30/2022
2022 Q2	8/12/2022	26	0.0%	38,710	6/30/2022
2022 Q1	5/16/2022	51	0.0%	60,196	3/31/2022
2021 Q4	2/14/2022	154	0.0%	94,461	12/31/2021
2021 Q3	11/15/2021	92	0.0%	38,043	9/30/2021
2021 Q1	5/13/2021	2	0.0%	421	3/31/2021
2020 Q4	2/9/2021	2	0.0%	823	12/31/2020
2020 Q3	11/5/2020	0	0.0%	756	9/30/2020
2020 Q2	8/13/2020	1	0.0%	715	6/30/2020
2020 Q1	5/14/2020	0	0.0%	203	3/31/2020
2019 Q4	2/14/2020	0	0.0%	33	12/31/2019